CD19 and central nervous system cancer: Park et al. engineered an OVV to generate a nonsignaling truncated CD19 protein (CD19t) that was a B-cell-lineage-restricted molecule.341 Infected with this armed OV, CD19-negative triple-negative breast and glioma tumor cells specifically expressed CD19t residing on the cell surface.